Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors, Primitive

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Completed

Docetaxel in Treating Patients With Solid Tumors

NCT00003565

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +54 more
Locations: Northeast Alabama Regional Medical Center Anniston, Alabama, United States

Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States

Veterans Affairs Medical Center - San Diego San Diego, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View all 74 locations

View Trial Details

Completed

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

NCT01365949

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +8 more
Locations: Not specified

View Trial Details

Completed

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

NCT01353300

Conditions: Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Digestive System Diseases, +36 more
Locations: Not specified

View Trial Details

Completed

Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma

NCT01493830

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Not specified

View Trial Details

Completed

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

NCT00049023

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +36 more
Locations: Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

View Trial Details

Completed

Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

NCT01510600

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Not specified

View Trial Details

Completed

Study of DNA in Blood Samples From Patients With Neuroblastoma

NCT00898391

Conditions: Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +13 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

NCT01585649

Conditions: Ewing Family of Tumors, Rhabdomyosarcoma, Myosarcoma, Neoplasms, +12 more
Locations: Teva Investigational Site 0103 Plovdiv, Bulgaria

Teva Investigational Site 0101 Sofia, Bulgaria

Teva Investigational Site 0102 Varna, Bulgaria

Teva Investigational Site 0201 Prague, Czechia

View all 18 locations

View Trial Details

Completed

Studying Gene Expression in Samples From Younger Patients With Neuroblastoma

NCT01553448

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Not specified

View Trial Details

Completed

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

NCT01387724

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Not specified

View Trial Details